Platelet monoamine oxidase molecular activity in demented patients

Italian Journal of Neurological Sciences

Volumn 18, Issue 3, 1997, Pages 151-156

  Bongioanni, P ^a   Gemignani, F ^a   Boccardi, B ^a   Borgna, M ^a   Rossi, B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer type dementia; monoamine oxidase molecular activity platelet monoamine oxidase; neurodegenerative disease

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; SEX DIFFERENCE; THROMBOCYTE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; SEX FACTORS;

EID: 0031158054     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02048483     Document Type: Article

References (27)

1. ADOLFSSON R, GOTTFRIES CG, ORELAND L, WIBERG A, WINBLAD B. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer tvpe. Life Sei, 1980; 27: 1029-1034.
2. ALEXOPOULOS GS, LIEBERMAN KW, YOUNG RC. Platelet MAO activity in primary degenerative dementia. Am J Psychiatry, 1984; 141: 97-99.
3. BELENDIUK K, BELENDIUK GW, FREEDMAN DX, ANTEL IP. Neurotransmitter abnormalities in patients with motor neuron disease. Arch Neurol, 1981, 38: 415-417.
4. BELMAKER RH, EBBESEN K, EBSTEIN R, RIMON R. Platelet monoamine oxidase in schizophrenia and manicdepressive illness. Br J Psychiatry, 1976; 129: 227-232.
5. BONGIOANNI P. Platelets as a model in neurological studies: biochemical and clinical features. Arch Psicol Neurol Psichiat, 1987; 48: 169-192.
6. BONGIOANNI P. Platelets as a model in psychiatric studies. Neurologia Psichiatrica Scienze Umane, 1988; 8: 582-618.
7. BONGIOANNI P, RIMONSSON T, DONATO M. Enhanced platelet monoamine oxidase activity as marker of degeneration in the central nervous system. Eur J Clin Invest, 1991; 21: 24.
8. BONGIOANNI P, RIMONSSON T, DONATO M. Platelet monoamine oxidase molecular activity in Parkinsonian patients. In: Proceedings of the European Conference on Parkinson's Disease and Extrapyramidal Disorders. Rome, Milan, London, John Libbey CIC, 1991: 157-161.
9. CRAIG IW, POWELL JF, BROWN GK, SUMMERS KM. Studies of human monoamine oxidase. In: Kamijo K, Usdin E, Nagatsu T eds., Monoamine oxidase: basic and clinical frontiers. Princeton: Excerpta Medica, 1982: 1832.
10. DENIELCZYK W, STREIFLER M, KONRADI C, RIEDERER P, MOLL G. Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand, 1988; 78: 730-736.
11. FRITZ RR, ABELL CW, DENNEY RM et al. Platelet MAO concentration and molecular activity: I. New methods using a MAO B-specific monoclonal antibody in a radioimmunoassay. Psychiatry Res, 1986; 17: 129-140.
12. HAMBLEY JW, JOHNSTON GAR. Uptake of gammaaminobutyric acid by human blood platelets: comparison with CNS uptake. Life Sei, 1985; 36: 2053-2058.
13. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry, 1960; 23: 56-62.
14. HUGHES CP, BERG L, DANZIGER WL, COHEN LA, MARTIN RL A new clinical scale for the staging of dementia. Br J Psychiat, 1982; 140: 566-572.
15. LOWRY OH, ROSEBROUGH NJ, FARR AL et al. Protein measurement with the folin phenol reagent. J Biol Chem, 1951; 193: 265-275.
16. MANGANO RM, SCHWARCZ R. The human platelet as a model for the glutamatergic neuron: platelet uptake of Lglutamate.i Neurochem, 1981; 36: 1067-1076.
17. [ 17] MANN JJ, CHIU E. Platelet monoamine oxidase activity in Huntington's chorea. J Neurol Neurosurg Psychiatry, 1978; 41: 809-812.
18. MANN JJ, STANLEY M, KAPLAN RD, SWEENEY J, NEOPHYTIDES A. Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. J Neurol Neurosurg Psychiatry, 1983; 46: 905910.
19. PlCCINI P, BONGIOANNI P, NUTI A, BONUCCELLl U, PACIFICI GM, MURATORIO A. Attività monoamino-ossidasica nelle piastrine di parkinsoniani. In: Proceedings of the XV Meeting of the Italian League against Parkinson's Disease and Extrapyramidal Disorders, Rome, Guanella Editore, 1989: 99-108.
20. PLETSCHER A. Platelets as models for monoaminergic neurons. In: Youdim MOB ed., Essays in Neurochemistry and Neuropharmacology (vol. 3). London, John Wiley & Sons, 1978: 49-101.
21. PLETSCHER A. Platelets as models: use and limitations. Experientia, 1988; 44: 152-155.
22. SAURA J, LUQUE JM, CESURA AM et al. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neurosci, 1994; 62: 15-30.
23. SMITH RC, Ho BT, KRALIK P, VROULIS MSG, GORDON J, WOLF J. Platelet monoamine oxidase in Alzheimer's Disease. J Gerontol, 1982; 37: 572-574.
24. YOUDIM MBH. Platelet monoamine oxidase B: use and misure. Experientia, 1988; 44: 137-141.
25. Yu PH, BOULTON AA. Activation of platelet monoamine oxidase by plasma in the human. Life Sei, 1979; 25: 3137.
26. ZELLER EA, BOSHES B, ARBIT J et al. Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase. J Neural Transm, 1976; 39: 63-77.
27. ZUBENKO GS, WUSYLKO M, BöLLER F, TEPLY I. Family study of platelet membrane fluidity in Alzheimer's disease. Science, 1987; 238: 539-542.